Skye Bioscience, Inc. · NASDAQ:SKYE

Andrew J. Schwab reported a 36.40% stake in Skye Bioscience, Inc. (Schedule 13D/A)

Event Dec 17, 2024 · Filed Dec 19, 2024

Andrew J. Schwab reported a 36.40% stake in Skye Bioscience, Inc., 11,696,895 shares, with active intent on Dec 17, 2024. Filed Dec 19, 2024 (Schedule 13D/A).

Stake
36.40%
Shares
11,696,895
Intent
Active
What changed
Stake changed
Filed together
9 holders

The filing in full

HolderStakeShares
5AM Partners VII, LLC30.80%9,872,599
5AM Ventures VII, L.P.30.80%9,872,599
5AM Partners II, LLC5.80%1,745,962
5AM Ventures II, L.P.5.50%1,679,685
5AM Co-Investors II, L.P.0.20%66,277
Andrew J. Schwab36.40%11,696,895
Kush Parmar30.80%9,872,599
John D. Diekman5.80%1,745,962
Scott M. Rocklage5.80%1,745,962

Source

View original at SEC

Related